These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 3597060)
1. Biological properties of the antagonist SRI 63-441 in the PAF and endotoxin models of hypotension in the rat and dog. Handley DA; Van Valen RG; Tomesch JC; Melden MK; Jaffe JM; Ballard FH; Saunders RN Immunopharmacology; 1987 Apr; 13(2):125-32. PubMed ID: 3597060 [TBL] [Abstract][Full Text] [Related]
2. Inhibition and reversal of endotoxin-, aggregated IgG- and paf-induced hypotension in the rat by SRI 63-072, a paf receptor antagonist. Handley DA; Van Valen RG; Melden MK; Flury S; Lee ML; Saunders RN Immunopharmacology; 1986 Aug; 12(1):11-6. PubMed ID: 3019921 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of PAF-induced systemic responses in the rat, guinea pig, dog and primate by the receptor antagonist SRI 63-441. Handley DA; Tomesch JC; Saunders RN Thromb Haemost; 1986 Aug; 56(1):40-4. PubMed ID: 3775689 [TBL] [Abstract][Full Text] [Related]
4. Effects of platelet-activating factor antagonist SRI 63-441 on endotoxin-induced changes in rat mesenteric microcirculation. Li SH; Fei X; Gong XQ; Wu ZL Yao Xue Xue Bao; 1991; 26(1):6-9. PubMed ID: 1887797 [TBL] [Abstract][Full Text] [Related]
5. Protective effect of SR 27417, a novel PAF antagonist, on PAF- or endotoxin-induced hypotension in the rat and the guinea-pig. Bernat A; Herbert JM; Salel V; Lespy L; Maffrand JP J Lipid Mediat; 1992 Feb; 5(1):41-8. PubMed ID: 1391738 [TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents. Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121 [TBL] [Abstract][Full Text] [Related]
7. Attenuation of endotoxin-induced increase in glucose metabolism by platelet-activating factor antagonist. Lang CH; Dobrescu C; Hargrove DM; Bagby GJ; Spitzer JJ Circ Shock; 1987; 23(3):179-88. PubMed ID: 3427772 [TBL] [Abstract][Full Text] [Related]
8. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat. Toth PD; Mikulaschek AW Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423 [TBL] [Abstract][Full Text] [Related]
9. Administration of a receptor antagonist for platelet-activating factor during equine endotoxaemia. Carrick JB; Morris DD; Moore JN Equine Vet J; 1993 Mar; 25(2):152-7. PubMed ID: 8385601 [TBL] [Abstract][Full Text] [Related]
10. Effects of in vivo 'priming' on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factor. Sun XM; Hsueh W; Torre-Amione G Am J Pathol; 1990 Apr; 136(4):949-56. PubMed ID: 2327475 [TBL] [Abstract][Full Text] [Related]
12. Effects of platelet-activating factor on rat mesenteric microcirculation. Li SH; Gong XQ; Fei X; Wu ZL Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):344-6. PubMed ID: 2104488 [TBL] [Abstract][Full Text] [Related]
13. Effect of the platelet activating factor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride on endotoxin-induced hypotension and hematological parameters in rats. Natsume Y; Imanishi N; Koike H; Morooka S Arzneimittelforschung; 1994 Nov; 44(11):1208-13. PubMed ID: 7848333 [TBL] [Abstract][Full Text] [Related]
14. Is platelet activating factor (PAF) a mediator of endotoxin shock? Terashita Z; Imura Y; Nishikawa K; Sumida S Eur J Pharmacol; 1985 Feb; 109(2):257-61. PubMed ID: 3996473 [TBL] [Abstract][Full Text] [Related]
15. Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412. Handley DA; Van Valen RG; Melden MK; Houlihan WJ; Saunders RN J Pharmacol Exp Ther; 1988 Nov; 247(2):617-23. PubMed ID: 3183958 [TBL] [Abstract][Full Text] [Related]
16. Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock. Casals-Stenzel J Eur J Pharmacol; 1987 Mar; 135(2):117-22. PubMed ID: 3582490 [TBL] [Abstract][Full Text] [Related]
17. Comparative hemodynamics and cardiovascular effects of endotoxin and platelet-activating factor in rat. Salari H; Demos M; Wong A Circ Shock; 1990 Nov; 32(3):189-207. PubMed ID: 2261677 [TBL] [Abstract][Full Text] [Related]
18. Interference of the PAF-acether antagonist BN 52021 with endotoxin-induced hypotension in the guinea-pig. Adnot S; Lefort J; Braquet P; Vargaftig BB Prostaglandins; 1986 Dec; 32(6):791-802. PubMed ID: 3562865 [TBL] [Abstract][Full Text] [Related]
19. Effect of platelet-activating factor receptor antagonism on endotoxin-induced lung dysfunction in awake sheep. Christman BW; Lefferts PL; Blair IA; Snapper JR Am Rev Respir Dis; 1990 Dec; 142(6 Pt 1):1272-8. PubMed ID: 2174655 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of the platelet activating factor (PAF)-induced in vivo responses in rats by trans-2,5-(3,4,5-trimethoxyphenyl) tetrahydrofuran (L-652,731), a PAF receptor antagonist. Wu MS; Biftu T; Doebber TW J Pharmacol Exp Ther; 1986 Dec; 239(3):841-5. PubMed ID: 3795043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]